The usefulness of the semiquantitative procalcitonin test kit as a guideline for starting antibiotic administration

American Journal of Emergency Medicine

Volumn 27, Issue 7, 2009, Pages 859-863

  Oh, Joo Suk ^a   Kim, Seong Uk ^a   Oh, Young Min ^a   Choe, Se Min ^a   Choe, Gyeong Ho ^a   Choe, Seung Pil ^a   Kim, Young Min ^a   Hong, Tae Yong ^a   Park, Kyu Nam ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROCALCITONIN;

ARTICLE; DIAGNOSTIC KIT; DIAGNOSTIC VALUE; DISEASE SEVERITY; EMERGENCY WARD; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CALCITONIN; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; GLYCOPROTEINS; HEALTH STATUS INDICATORS; HUMANS; IMMUNOASSAY; INFANT; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; SHOCK, SEPTIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; YOUNG ADULT;

EID: 68349086998     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.06.021     Document Type: Article

References (13)

1. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32 (2004) 858-873
2. Kumar A., Roberts D., Wood K.E., et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34 (2006) 1589-1596
3. Bone R.C., Balk R.A., Cerra F.B., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 (1992) 1644-1655
4. Assicot M., Gendrel D., Carsin H., et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 (1993) 515-518
5. Brunkhorst F.M., Wegscheider K., Forycki Z.F., et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock. Intensive Care Med 26 (2000) S148-S152
6. Selberg O., Hecker H., Martin M., et al. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6. Crit Care Med 28 (2000) 2793-2798
7. Giamarellos-Bourboulis E.J., Mega A., Grecka P., et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient?. Intensive Care Med 28 (2002) 1351-1356
8. Arkader R., Troster E.J., Lopes M.R., et al. Procalcitonin does discriminate between sepsis and systemic inflammatory response syndrome. Arch Dis Child 92 (2006) 117-120
9. Fink M.P. Bench-to-bedside review: cytopathic hypoxia. Crit Care 6 (2002) 491-499
10. Ho K.M., Dobb G.J., Knuiman M., et al. A comparison of admission and worst 24-hour Acute Physiology and Chronic Health Evaluation II scores in predicting hospital mortality: a retrospective cohort study. Crit Care 10 (2006) R4
11. Man S.Y., Chan K.M., Wong F.Y., et al. Evaluation of the performance of a modified Acute Physiology and Chronic Health Evaluation (APACHE II) scoring system for critically ill patients in emergency departments in Hong Kong. Resuscitation 74 (2007) 259-265
12. Shime N., Kageyama K., Ashida H., et al. Application of modified sequential organ failure assessment score in children after cardiac surgery. J Cardiothorac Vasc Anesth 15 (2001) 463-468
13. Dubos F., Moulin F., Gajdos V., et al. Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. J Pediatr 149 (2006) 72-76